CLASS ACTION UPDATE for FULC, DIS and ATLX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

PRESS RELEASE
Published June 7, 2023

NEW YORK, NY / ACCESSWIRE / June 7, 2023 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

FULC Shareholders Click Here: https://zlk.com/pslra-1/fulcrum-lawsuit-submission-form?prid=40455&wire=1
DIS Shareholders Click Here: https://zlk.com/pslra-1/disney-lawsuit-submission-form?prid=40455&wire=1
ATLX Shareholders Click Here: https://zlk.com/pslra-1/atlas-lithium-lawsuit-submission-form?prid=40455&wire=1

* ADDITIONAL INFORMATION BELOW *

Levi & Korsinsky, LLP, Wednesday, June 7, 2023, Press release picture

Fulcrum Therapeutics, Inc. (NASDAQ:FULC)

FULC Lawsuit on behalf of: investors who purchased March 3, 2022 - March 8, 2023
Lead Plaintiff Deadline : June 27, 2023
TO LEARN MORE, VISIT: https://zlk.com/pslra-1/fulcrum-lawsuit-submission-form?prid=40455&wire=1

According to the filed complaint, during the class period, Fulcrum Therapeutics, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the preclinical data submitted in support of FTX-6058 (an investigational oral fetal hemoglobin inducer for the treatment of sickle cell disease and other hemoglobinopathies) showed safety concerns regarding potential hematological malignancies; (ii) the foregoing safety concerns increased the likelihood that the FDA would place a clinical hold on preclinical studies of FTX-6058; (iii) accordingly, the Company had overstated FTX-6058's clinical and/or commercial prospects; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

The Walt Disney Company (NYSE:DIS)

DIS Lawsuit on behalf of: investors who purchased December 10, 2020 - November 8, 2022
Lead Plaintiff Deadline : July 11, 2023
TO LEARN MORE, VISIT: https://zlk.com/pslra-1/disney-lawsuit-submission-form?prid=40455&wire=1

According to the filed complaint, during the class period, The Walt Disney Company made materially false and/or misleading statements and/or failed to disclose that: (a) Disney+ was suffering decelerating subscriber growth, losses, and cost overruns; (b) the true costs incurred in connection with Disney+ had been concealed by Disney executives by debuting certain content intended for Disney+ initially on Disney's legacy distribution channels and then making the shows available on Disney+ thereafter in order to improperly shift costs out of the Disney+ segment; (c) Disney Media and Entertainment Distribution had made platform distribution decisions based not on consumer preference, consumer behavior, or the desire to maximize the size of the audience for the content as represented, but based on the desire to hide the full costs of building Disney+'s content library; (d) the Company was not on track to achieve its 2024 Disney+ paid global subscriber and profitability targets, that such targets were not achievable, and that such estimates lacked a reasonable basis in fact; and (e) as a result of (a)-(d) above, defendants had materially misrepresented the actual performance of Disney+, the sustainability of Disney+'s historical growth trends, the profitability of Disney+, and the likelihood that Disney could achieve its 2024 Disney+ subscriber and profitability targets.

Atlas Lithium Corporation (NASDAQ:ATLX)

ATLX Lawsuit on behalf of: investors who purchased March 25, 2022 - May 3, 2023
Lead Plaintiff Deadline : August 1, 2023
TO LEARN MORE, VISIT: https://zlk.com/pslra-1/atlas-lithium-lawsuit-submission-form?prid=40455&wire=1

According to the filed complaint, during the class period, Atlas Lithium Corporation made materially false and/or misleading statements and/or failed to disclose that: (i) the Company overstated the success of its lithium mining and misrepresented the nature of its Brazilian mineral rights; (ii) in connection with these misrepresentations, Atlas Lithium conducted deceptive promotions to artificially inflate the value of the Company's stock; (iii) the foregoing conduct was designed to allow CEO Fogassa and other Company insiders to sell shares back into the market for a profit before the true nature of Atlas Lithium's business was revealed; and (iv) as a result, defendants' public statements were materially false and/or misleading at all relevant times.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Eduard Korsinsky, Esq.
55 Broadway, 4th Floor Suite #427
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP



View source version on accesswire.com:
https://www.accesswire.com/759773/CLASS-ACTION-UPDATE-for-FULC-DIS-and-ATLX-Levi-Korsinsky-LLP-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders

ACCESSWIRE

News network reaching more than 1,500 media outlets in 98 countries. The newest, fastest-growing and most disruptive newswire available today.